Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
---|
11/02/2000 | WO2000064436A1 Methods of delivery of cetyl myristoleate |
11/02/2000 | WO2000046235B1 Novel betulinic acid derivatives, processes for preparing such derivatives and its use as cancer growth inhibitors |
11/02/2000 | WO2000040714A3 Therapeutic phosphodiesterase inhibitors |
11/02/2000 | WO2000040172B1 Composition and formulations and their use as nociceptic, anti-anxiolytic and anabolic agents |
11/02/2000 | WO2000039299A3 Streptococcus antigens |
11/02/2000 | WO2000039279A3 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
11/02/2000 | WO2000038730A3 Use of a cyclooxygenase-2 inhibitor and one or more antineoplastic agents for combination therapy in neoplasia |
11/02/2000 | WO2000035408A3 Method for treatment of bacterial infections with once or twice-weekly administered rifalazil |
11/02/2000 | WO2000033878A3 Stabilization of macrolides |
11/02/2000 | WO2000033863A3 Therapeutic agent for the suppression of snoring noises |
11/02/2000 | EP1048725A1 Process for production of mammalian cell lines, produced cell lines and their uses |
11/02/2000 | EP1048658A1 Alicyclic acylated heterocyclic derivatives |
11/02/2000 | EP1048657A1 Thienyl-, furyl-, pyrrolyl- and biphenylsulfonamides and derivatives thereof that modulate the activity of endothelin |
11/02/2000 | EP1047782A1 Interleukin-1 receptor antagonist beta (il-1ra beta) |
11/02/2000 | EP1047698A1 Piperazino derivatives as neurokinin antagonists |
11/02/2000 | EP1047688A1 Thiophene nitrone compounds |
11/02/2000 | EP1047683A1 Thioether furan nitrone compounds |
11/02/2000 | EP1047675A1 Chemokine receptor antagonists and methods of use therefor |
11/02/2000 | EP1047395A1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative |
11/02/2000 | EP0888316B1 2-(3h)-oxazolone derivatives and their use as cox-2 inhibitors |
11/02/2000 | DE19917990A1 Arzneimittel enthaltend Hemmstoffe der zellvolumenregulierten humanen Kinase h-sgk Medicines containing inhibitors of cell volume-regulated human kinase h-sgk |
11/02/2000 | CA2371064A1 Methods of delivery of cetyl myristoleate |
11/02/2000 | CA2370391A1 Method for down-regulating il5 activity |
11/02/2000 | CA2370306A1 Treatment of fibrosis by antagonism of il-13 and il-13 receptor chains |
11/02/2000 | CA2369999A1 Enzymatically activated polymeric drug conjugates |
11/02/2000 | CA2369092A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors |
11/02/2000 | CA2368213A1 Specifically targeted catalytic antagonists and uses thereof |
11/02/2000 | CA2367965A1 Human gil-19/ae289 proteins and polynucleotides encoding same |
11/01/2000 | CN1272058A Perforated microparticles and methods of use |
11/01/2000 | CN1058019C 环状氨基酸衍生物 Cyclic amino acid derivatives |
11/01/2000 | CN1058008C Phenyl heterocycles as cyclooxygenase-2 inhibitors |
10/31/2000 | US6140466 Comprises at least three zinc finger domains that bind to target cellular nucleotide sequence and modulate its transcription; genome-specific transcriptional switches in gene therapy; transgenic plants and animals |
10/31/2000 | US6140352 Carbazolyl-substituted ethanolamines as selective β-3 agonists |
10/31/2000 | US6140344 For treating pathological conditions such as asthma, rhinitis, eczema and parasitic infections featuring tissue eosinophilia |
10/31/2000 | US6140335 Use of mizolastine for treating inflammatory diseases associated with 5-lipoxygenase |
10/31/2000 | US6140327 Morpholino-n-ethyl ester derivative of an indole sPLA2 inhibitor |
10/31/2000 | US6140061 Response regulator |
10/31/2000 | US6139864 A food or medicine containing a zinc compound and an antimicrobially effective amount of a sugar alcohol mixture without complexing with zinc compound; treatment and prevention of viral cold |
10/31/2000 | US6139860 Method of stimulating cilia |
10/31/2000 | US6138683 Smokeless tobacco products containing antioxidants |
10/27/2000 | CA2307108A1 Process for production of mammalian cell lines, produced cell lines and their uses |
10/26/2000 | WO2000063415A1 Dna encoding the human vanilloid receptor vr1 |
10/26/2000 | WO2000063374A1 Synthetic transmembrane components |
10/26/2000 | WO2000063372A1 Synthetic signalling molecules |
10/26/2000 | WO2000063371A1 Protease activated receptor 2 variants |
10/26/2000 | WO2000063252A1 Anti-idiotypic antibodies against antibodies which inhibit the binding of immunoglobuline to its high affinity receptor |
10/26/2000 | WO2000063234A2 Pyrrolidincarbonylamino cyclic disulfides as vcam-vla4 antagonists |
10/26/2000 | WO2000063221A2 Galectin 11 |
10/26/2000 | WO2000063218A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents |
10/26/2000 | WO2000063210A1 Morphinoid compounds |
10/26/2000 | WO2000063204A2 Substituted azoles |
10/26/2000 | WO2000063181A1 Use of maduraphthalazine derivatives as inhibitors of pro-inflammatory cytokins |
10/26/2000 | WO2000063159A1 (-)-verbenone derivatives |
10/26/2000 | WO2000062801A2 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
10/26/2000 | WO2000062797A1 Remedies for autonomic neuropathy |
10/26/2000 | WO2000062781A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk |
10/26/2000 | WO2000062778A1 Cyclic protein tyrosine kinase inhibitors |
10/26/2000 | WO2000062766A2 Uses of ppar-gamma agonists in neutrophil-induced diseases |
10/26/2000 | WO2000062736A2 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion |
10/26/2000 | WO2000039275A3 Multiple shear stress responsive elements (ssre) and methods of use thereof |
10/26/2000 | WO2000037099A3 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor |
10/26/2000 | WO2000027815A3 N-substituted azacycles, their preparation and their use as orl-1 receptor ligands |
10/26/2000 | WO2000025746A3 A process for the preparation of suspensions of drug particles for inhalation delivery |
10/26/2000 | WO2000018230A9 Combination of bisphosphonate and tetracycline |
10/26/2000 | WO2000017191A3 N-(iminomethyl)amine derivatives, their preparation, their use as medicines and compositions containing them |
10/26/2000 | WO2000017190A3 Amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
10/26/2000 | CA2371611A1 Galectin 11 |
10/26/2000 | CA2370570A1 Dna encoding the human vanilloid receptor vr1 |
10/26/2000 | CA2370417A1 Substituted azoles |
10/26/2000 | CA2370272A1 Protease activated receptor 2 variants |
10/26/2000 | CA2370259A1 Pyrrolidincarbonylamino cyclic disulfides |
10/26/2000 | CA2370146A1 Ruthenium dimeric complexes suitable as antimetastatic and antineoplastic agents |
10/26/2000 | CA2370127A1 Novel method of treatment |
10/26/2000 | CA2369078A1 Medicaments containing inhibitors of cell-volume regulated human kinase h-sgk |
10/26/2000 | CA2367367A1 (-)-verbenone derivatives |
10/26/2000 | CA2365579A1 Combination vaccine against streptococcus pneumoniae and respiratory syncytial virus (rsv) |
10/26/2000 | CA2330022A1 Low adenosine anti-sense oligonucleotide, compositions, kit and method for treatment of airway disorders associated with bronchoconstriction, lung inflammation, allergy(ies) and surfactant depletion |
10/25/2000 | EP1045908A2 Human urotensin ii |
10/25/2000 | EP1045851A1 Substituted porphyrins |
10/25/2000 | EP1045850A1 Purine compounds having pde iv inhibitory activity and methods of synthesis |
10/25/2000 | EP1045849A1 Purine derivatives having phosphodiesterase iv inhibition activity |
10/25/2000 | EP1045845A1 N-oxides of heterocyclic compounds with tnf and pde-iv inhibiting activity |
10/25/2000 | EP1045822A1 Certain diterpenes and extracts or concentrates of curcuma amada containing them for use as medicaments |
10/25/2000 | EP1045695A1 Use of 9-deoxy-2', 9-alpha-methano-3- oxa-4,5,6- trinor-3, 7-(1',3'-interphenylene) -13,14-dihydro- prostaglandin f 1? to treat peripheral vascular disease |
10/25/2000 | EP1045690A1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use |
10/25/2000 | CN1271359A Novel compounds |
10/25/2000 | CN1271287A New use of budesonide and formoterol |
10/25/2000 | CN1271279A Amide derivatives for the treatment of diseases mediated by cytokines |
10/25/2000 | CN1270959A 4-phenyl pyridine derivatives |
10/25/2000 | CN1270838A Adjuvant used in vaccine |
10/25/2000 | CN1270814A Cough and asthma relieving and phlegm eliminating capsule and its preparation |
10/25/2000 | CN1057772C Compounds and compositions for treatment of immunomediated inflammatory disorders |
10/25/2000 | CN1057689C Chuanyusan-granule for curing asthmoid |
10/24/2000 | US6136974 Pyrrolo[3,4-D]Pyrimidinone derivatives and their use as medicaments |
10/24/2000 | US6136848 Antiallergens; asthma therapy |
10/24/2000 | US6136843 Indole derivatives useful as endothelin receptor antagonists |
10/24/2000 | US6136839 Using a sulfone or sulfoamide benzene compound |
10/24/2000 | US6136821 Naphthyridine derivatives |
10/24/2000 | US6136603 Oligonucleotides which target the untranslated region of a cytokine receptor gene; for treatment of eosinophil defects such as asthma, rhinitis and dermatitis; wound healing agents; antiinflammatory agents; anticarcinogenic agents |
10/24/2000 | US6136596 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |